| Literature DB >> 31426346 |
Yuya Fujitaka1, Hiroki Hamada2, Daisuke Uesugi1, Atsuhito Kuboki3, Kei Shimoda4, Takafumi Iwaki5, Yuya Kiriake6, Tomohiro Saikawa7.
Abstract
Daidzein is a common isoflavone, having multiple biological effects such as anti-inflammation, anti-allergy, and anti-aging. α-Tocopherol is the tocopherol isoform with the highest vitamin E activity including anti-allergic activity and anti-cancer activity. Hesperetin is a flavone, which shows potent anti-inflammatory effects. These compounds have shortcomings, i.e., water-insolubility and poor absorption after oral administration. The glycosylation of bioactive compounds can enhance their water-solubility, physicochemical stability, intestinal absorption, and biological half-life, and improve their bio- and pharmacological properties. They were transformed by cultured Nicotiana tabacum cells to 7-β-glucoside and 7-β-gentiobioside of daidzein, and 3'- and 7-β-glucosides, 3',7-β-diglucoside, and 7-β-gentiobioside of hesperetin. Daidzein and α-tocopherol were glycosylated by galactosylation with β-glucosidase to give 4'- and 7-β-galactosides of daidzein, which were new compounds, and α-tocopherol 6-β-galactoside. These nine glycosides showed higher anti-allergic activity, i.e., inhibitory activity toward histamine release from rat peritoneal mast cells, than their respective aglycones. In addition, these glycosides showed higher tyrosinase inhibitory activity than the corresponding aglycones. Glycosylation of daidzein, α-tocopherol, and hesperetin greatly improved their biological activities.Entities:
Keywords: anti-allergic activity; daidzein; hesperetin; tyrosinase inhibitory activity; α-tocopherol; β-glycoside
Mesh:
Substances:
Year: 2019 PMID: 31426346 PMCID: PMC6721765 DOI: 10.3390/molecules24162975
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of daidzein, α-tocopherol, and hesperetin.
Figure 2Synthetic schemes of glycosides of daidzein and hesperetin.
Figure 3Synthetic schemes of galactosides of daidzein and α-tocopherol.
Figure 4HMBC correlations of daidzein galactosides.
Anti-allergic activities of compounds 1–5.
| Compound | Histamine Release-Inhibiting Activity / %inhibition 1 |
|---|---|
|
| 80 |
|
| 58 |
|
| 62 |
|
| 67 |
|
| 70 |
|
| 76 |
|
| 61 |
|
| 82 |
|
| 38 |
|
| 40 |
|
| 45 |
|
| 63 |
|
| 69 |
1 Histamine release-inhibiting activity is expressed as %inhibition.
Tyrosinase inhibitory activities of compounds 1–5.
| Compound | Tyrosinase Inhibitory Activity IC50 1 / μM |
|---|---|
|
| 35 ± 15 |
|
| 392 ± 88 |
|
| 303 ± 45 |
|
| 280 ± 33 |
|
| 125 ± 41 |
|
| 102 ± 39 |
|
| 510 ± 108 |
|
| 54 ± 25 |
|
| 437 ± 76 |
|
| 355 ± 32 |
|
| 318 ± 27 |
|
| 176 ± 35 |
|
| 139 ± 14 |
1 Tyrosinase inhibitory activity is expressed as the 50% inhibitory concentration (IC50). The results are shown as the mean ± standard deviation from triplicate experiments.